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ABSTRACT
Hormones are specific regulatory molecules that have potent
effects on the major determinants of the development and the
integrity of the skeleton and oral cavity including periodontal
tissues. Sex hormones have long been considered to play an
influential role on periodontal tissues, bone turnover rate, wound
healing and periodontal disease progression. This review focuses
on the effects of endogenous sex hormones on the periodontium
and the goal is to inform and update practitioners’ knowledge about
the impact of these hormones on periodontal status.
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INTRODUCTION
Hormones are specific regulatory molecules that modulate
reproduction, growth, development and the maintenance of
internal environments as well as energy production, utilization
and storage.1 Hormones can be classified into four groups
based upon their chemical structure, including steroids,
glycoproteins, polypeptides and amines.2 Researchers have
shown that changes in periodontal conditions might be
associated with variations in sex hormone levels.
Sex hormones likely influence the pathogenesis of
periodontal diseases.3 This association is evident in the recent
periodontal disease classification, which includes the
following hormone-related disease categories: Puberty-
associated gingivitis, menstrual cycle-associated gingivitis and
pregnancy-associated gingivitis.4 Therefore, the goal of this
review paper is to discuss how sex hormones may influence
the periodontium.
Steroid Sex Hormones
Steroid sex hormones are derived from cholesterol and as a
common structure they have three rings of six carbon atoms.
They are believed to play an important role in the maintenance
of the skeletal integrity, including the alveolar bone. The
steroid sex hormones, such as estrogen and estradiol have been
known for their effect on bone mineral metabolism. Other
bone turnover-related hormones include progesterone,
testosterone and dihydrotestosterone, androstenedione,
dihydroepiandrostenedione, and sex hormone-binding
globulin.5 Among these, estrogens, progesterone and androgen
(testosterone) have been most linked with periodontal
pathogenesis.
In women, estrogen and progesterone contribute to
physiological changes at specific life phases. Puberty,
menstrual cycle, pregnancy and menopause are all phases that
specifically influence oral and periodontal health in women.
Increased hormonal levels during puberty affect gingival
tissues and the subgingival microflora.6 For example, during
puberty, Prevotella intermedia and Capnocytophaga bacterial
species emerge.7 Moreover, bleeding may occur when patients
masticate or brush their teeth. In addition to puberty-induced
changes, gingival tissues are more edematous during the
menstrual cycle and erythematous before its onset.
Consequently, increased gingival bleeding and exudation8 has
been observed during the menstrual period and is sometimes
associated with slight increases in tooth mobility.9
Androgens (Testosterone)
Androgens are hormones responsible for masculinization.
Testosterone can be produced in the adrenal cortex, although
the one from the testes is the most active form.10 Its secretion
is regulated by ACTH and by pituitary adrenal androgen-
stimulating hormone. The adrenal androgen androstenedione
is converted to testosterone and to estrogens in the circulation
and represents an important source of estrogens in men and in
postmenopausal women. Specific receptors for this hormone
have been isolated in the periodontal tissues.11 Interestingly,
the number of receptors in fibroblasts tends to increase in
inflamed or overgrown gingiva. It is believed that an increasing
matrix synthesis occurs on periodontal cells under testosterone
influence.12 Testosterone has also been associated with bone
metabolism, playing a role in the maintenance of bone mass.13
Kasperk et al observed that both gonadal androgen
dihydrotesterone (DHT) and adrenal androgen dehydro-
epiandrosterone (DHEA) have a positive impact on bone
metabolism, by stimulating bone cell proliferation and
differentiation.14 A very effective way to analyze the effect of
androgens on bone metabolism is the evaluation of the
presence of biochemical markers of bone remodeling on bone
tissue under the influence of those hormones. One of the bone
remodeling markers that has been used for this objective is
osteoprotegerin (OPG), which is a secreted decoy receptor
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that inhibits osteoclast formation and activation by neutralizing
its cognate ligand. This OPG action has been associated with
a reduction in the loss of bone mineral density that is observed
during periodontal disease progression.15
Effects of Androgens on the Periodontal Tissues
• Inhibit prostaglandin secretion16
• Enhance osteoblast proliferation and differentiation13
• Reduce IL-6 production during inflammation17
• Enhance matrix synthesis by periodontal ligament
fibroblasts and osteoblasts.18
Estrogen and Progesterone
Estrogen and progesterone are responsible for physiological
changes in women at specific phases of their life, starting in
puberty. Estrogen induces several of the pubertal developmental
changes in females, and progesterone acts synergistically with
estrogen to control the menstrual cycle and to inhibit follitropin
secretion by the anterior pituitary gland.19 Specifically,
estrogens can influence the cytodifferentiation of stratified
squamous epithelium as well as the synthesis and maintenance
of fibrous collagen.19 Estrogen receptors found in osteoblast-
like cells provide a mechanism for the direct action on bone.
These receptors were also located in periosteal fibroblasts,
scattered fibroblasts of the lamina propria20 and periodontal
ligament (PDL) fibroblasts,21 proving the direct action of sex
hormones on different periodontal tissues.
Effects of Estrogen on the Periodontal Tissues
• Decreases keratinization while increasing epithelial
glycogen that results in the diminution in the effectiveness
of the epithelial barrier22
• Increases cellular proliferation in blood vessels23
• Stimulates PMNL phagocytosis24
• Inhibits PMNL chemotaxis25
• Suppress leukocyte production from the bone marrow26
• Inhibits proinflammatory cytokins released by human
marrow cells26
• Reduces T-cell mediated inflammation27
• Stimulates the proliferation of the gingival fibroblasts26
• Stimulates the synthesis and maturation of gingival
connective tissues28
• Increases the amount of gingival inflammation with no
increase of plaque.29
Effects of Progesterone on the Periodontal Tissues
• Increases vascular dilatation, thus increases permeability30
• Increases the production of prostaglandins31
• Increases PMNL and prostaglandin E2 in the gingival
crevicular fluid (GCF)32
• Reduces glucocorticoid anti-inflammatory effect33
• Inhibits collagen and noncollagen synthesis in PDL
fibroblast34
• Inhibits proliferation of human gingival fibroblast
proliferation
• Alters rate and pattern of collagen production in gingiva
resulting in reduced repair and maintenance potential35
• Increases the metabolic breakdown of folate which is
necessary for tissue maintenance and repair.36
PERIODONTAL MANIFESTATIONS RELATED TO
ENDOGENOUS SEX HORMONES
Puberty
Puberty marks the initiation of changes from maturation into
adulthood.37 It is associated with a major increase in the
secretions of the sex steroid hormones: Testosterone in males
and estradiol in females. Several cross-sectional and
longitudinal studies have demonstrated an increase in gingival
inflammation without accompanying an increase in plaque
levels during puberty.38
There is a higher incidence of black-pigmented bacteroides
and higher populations of other Gram-negative rods in the
subgingival microflora compared with healthy sulci in
puberty.39 Especially, there is an increased prevalence of
certain bacterial species, such as Prevotella intermedia and
Capnocytophaga species.40 Both estradiol and progesterone
have been shown to selectively accumulate by P.intermedia
as a substitute for vitamin K, and thus postulated to be acting
as a growth factor for this microorganism.41 Capnocytophaga
species have also been noted to increase in number as well as
proportion in the subgingival milieu during puberty and have
been shown to correlate with an increased bleeding tendency.40
Clinical and Microbial Changes in the Periodontal
Tissues during Puberty
• Increased gingival inflammation without accompanying an
increase in plaque levels39
• Increased prevalence of certain bacterial species such, as
P. intermedia and Capnocytophaga species.11
Menstruation
The onset of increased production, and secretion of estrogen
and progesterone in a cyclic pattern accompanies the onset of
puberty and is referred to as the reproductive or menstrual
cycle. The duration of normal reproductive cycle is 28 days,
and the monthly reproductive cycle has two phases.42
During the menstrual cycle, progesterone peaks at
approximately 10 days (increases from the second week), and
drops prior to menstruation.43 Progesterone has been associated
with increased permeability of the microvasculature, altering
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the rate and the pattern of collagen production in the gingiva,
increases folate metabolism, stimulates the production of
prostaglandins and enhances the chemotaxis of
polymorphonuclear leukocytes (PMNL).44 As a result,
significant gingival inflammatory changes have been
documented in association with the menstrual cycle, and
gingival inflammation seems to be aggravated by an imbalance
and/or increase in sex hormones.45 Bleeding and a swollen
gingivae,37,45,46 an increase in gingival exudates40 and a minor
increase in tooth mobility have all been demonstrated during
menses.45 A gradual increase in gingival fluid occurs during
the proliferation phase just before menstruation,46 where an
increase in the production of estrogen and progesterone is
observed. Nevertheless, most women with a clinically healthy
periodontium experience few significant changes as a result
of menstruation.
Clinical Changes in the Periodontal Tissues
during Menstruation
• Bleeding and swollen gingiva45
• An increase in gingival exudates47
• A minor increase in tooth mobility.45
Pregnancy
Some of the most remarkable endocrine-related oral
alterations occur during pregnancy due to increased plasma
hormone levels. Progesterone and estrogen reach their peak
plasma levels of 100 and 6 ng/ml respectively, by the end of
the third trimester, and the potential biological impact of
estrogen and progesterone take place in periodontal tissues
during this period.48
Pregnancy gingivitis is extremely common occurring in a
range between 30 and 100% of all pregnant women.49 Pinard
first described this situation in 1877 characterized with
erythema, edema, hyperplasia and increased bleeding.50 Cases
range from mild inflammation to severe hyperplasia, pain and
bleeding. Increased gingival probing depths, increased gingival
inflammation, increased gingival crevicular fluid flow
increased bleeding upon probing and increased tooth mobility51
are the clinical periodontal manifestations that have been
described during pregnancy. The anterior region of the mouth
is more commonly affected and the interproximal sites tend
to be the most involved areas.
Gingival inflammatory changes in pregnancy usually begin
during the second month and the severity of the disease
increases through the eight month, after which there is an
abrupt decrease related to a concomitant reduction in sex
steroid hormone secretion. Moreover, it has been confirmed
that during pregnancy the severity of gingival inflammation is
correlated to elevations of sex steroid hormones and is reduced
following parturition and the concomitant drop-off in hormone
production.51 There is also an increased incidence of pyogenic
granulomas during pregnancy at a prevalence of 0.2 to 9.6%.37
The ‘pregnancy tumor’ or ‘pregnancy-associated pyogenic
granuloma’ appears most commonly during the second or the
third month of pregnancy. Gingiva is the most common site
involved (70%) followed by tongue, lips, buccal mucosa and
the palate.52 The pregnancy tumor develops as a result of an
exaggerated inflammatory response to local irritations, then
enlarges rapidly and bleeds easily, and becomes hyperplastic
and nodular. The tumor may be sessile or pedunculated and
may range from purplish red to deep blue in color with small
fibrin spots.
Increased sex steroid hormones have effects on gingival
vasculature, subgingival microbiata, specific cells of
periodontium and local immune system during pregnancy.
Increased edema, erythema, gingival crevicular exudate and
hemorrhagic gingival tissues may also be observed due to the
effects of estrogen and progesterone on the gingival
vasculature.37,51
Kornman and Loesche53 reported that increased levels of
estrogen and progesterone paralleled gingival conditions and
the proportions of P. intermedia during pregnancy. During
the second trimester, an increase in gingivitis and gingival
bleeding without an increase in plaque levels have been reported
and further a 55-fold of an increase in the proportion of
P. intermedia has been reported in pregnant women compared
to nonpregnant controls.52
Clinical and Microbial Changes in the Periodontal
Tissues during Pregnancy
• Increased gingival probing depths51
• Increased gingival inflammation54
• Increased gingival crevicular fluid flow51
• Increased bleeding upon probing55
• Increased tooth mobility45
• Increased incidences of pyogenic granulomas
• Increased numbers of periodontopathogens especially
P. gingivalis and P. intermedia.53
Menopause and Postmenopause
Menopause usually begins between 45 and 55 years of age
unless accelerated by hysterectomy and/or ovariectomy.37 The
levels of estrogen begin to drop mainly during the late
follicular and luteal phase of the menstrual cycle when women
approach menopause.56
Katz and Epstein5 suggested that peripheral conversion of
androgens to estrogens might be the main factor for protecting
bone since estrogens have inhibitory effects on osteoclastic
functions. The postmenopausal period is associated with an
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increased risk of osteoporotic fractures, myocardial
infarction, menstrual cycle disorders, hot flushes, night
sweats, vaginal dryness and possibly with an early onset of
Alzheimer’s disease.57 The most significant problem that
develops during menopause is osteoporosis.37
Osteoporosis is a worldwide disease characterized by low
bone mass and fragility and a consequent increase in fracture
risk. Osteoporosis is also responsible for less crestal alveolar
bone per unit volume, a condition that may promote quicker
bone loss when encountered with infections, such as
periodontal infections.58 Women may demonstrate
menopausal gingivostomatitis and the clinical signs of this
disease are drying of the oral tissues, abnormal paleness of
the gingival tissues, redness and bleeding on probing and
brushing.59 Oral discomfort is also commonly reported by
postmenopausal women with burning sensation, xerostomia
and bad taste.
Clinical Changes in the Periodontal Tissues during
Menopause and Postmenopause
• Reduction in epithelial keratinization60
• A reduction in salivary gland flow61
• Drying of the oral tissues59
• Redness and abnormal paleness of the gingival tissues59
• Bleeding on probing and brushing.59
Contraceptives
Hormonal contraceptives induce a hormonal condition that
stimulates a state of pregnancy to prevent ovulation by the use
of gestational hormones. Oral contraceptive agents are one
of the most commonly used classes of drugs. The most
commonly used contraceptives nowadays consist of low doses
of estrogens (30 mg/day) and/or progestins (1.5 mg/day).62-64
The influence of contraceptives on the periodontium is not
limited to increases in inflammation and in the amount of
gingival exudates.65
These drugs have also been associated with an increase in
the prevalence of dry socket after dental extraction,66 and
accelerated progression of periodontal disease (higher gingival
index scores and more loss of attachment) when they are used
long-term. In contrast, some authors have found no significant
influences on the periodontal clinical parameters when
comparing oral contraceptives to nonmedicated control
groups.67
Hormone Replacement Therapy in
Postmenopausal Women
Osteoporosis, which is defined as a systemic condition
characterized by a decrease in the bone mineral density of at
least 2.5 times the normal values in a healthy young female, is
a major health problem in postmenopausal women. In Western
societies, more than one-third of the female population above
the age of 65 years suffers from signs and symptoms of
osteoporosis, a disorder characterized by low bone mass.
Estrogen deficiency is the dominant pathogenic factor for
osteoporosis in women. Although hormonal replacement in
an adequate dosage can slow or prevent bone loss, only a small
percentage of postmenopausal women receive such therapy,
and many who do fail to comply with the prescribed regimen
because of the fear of cancer, irregular bleeding and other
minor side effects.68 Progesterone alone is not effective in
preventing postmenopausal bone and tooth loss, but when
combined with estrogen it is believed to uncouple formation
and resorption to diminish bone resorption induced by
estrogen.69 Paganini-Hill70 analyzed the effects of estrogen
replacement therapy (ERT) on the prevention of tooth loss
and the need for dentures in older women. Results from this
study indicated that the proportion of edentulous women
decreased with increasing duration of ERT. It was concluded
that ERT may be beneficial in preventing tooth loss and the
need for dentures in older women. The available data indicates
that hormone replacement therapy should be suggested for
women during menopause since, several pathologic conditions
common during this period of time can be avoided or at least
reduced in severity.
CONCLUSION
Sexual hormones play an important role in influencing
periodontal disease progression and wound healing. These
effects are different depending on the gender as well as the
lifetime period analyzed. It is also clear that not all patients
and their periodontium respond in the same way to similar
amounts of circulating sexual hormones. In addition, the
influence of sex hormones can be minimized with good plaque
control as well as with hormone replacement therapies;
however, the true mechanism of how these interactions
actually occur remains to be determined.
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